Correspondence 0001213900-23-038677 from Norhart Invest LLC (CIK 0001964262)
Norhart Invest LLC (CIK 0001964262)
Date: May 11, 2023 · CIK: 0001964262 · Accession: 0001213900-23-038677
AI Filing Summary & Sentiment
File numbers found in text: 024-12163
Referenced dates: May 10, 2023
Show Raw Text
CORRESP
1
filename1.htm
Donald T. Locke, Attorney at Law
10505 Byrum Woods Drive
Raleigh, NC 27613
Email: donlocke2244@gmail.com
Cell: (919) 264-4081
May 11, 2023
By Email – ParkKi@SEC.GOV; NicholsonKe@SEC.GOV
United States Securities and Exchange Commission
Washington, D.C. 20549
Attn: Kibum Park
Kenisha Nicholson
Re: Norhart Invest LLC (the “Company”)
Response to SEC Comments on
Amendment No. 2 to Offering Statement on Form 1-A Filed April 26, 2023
File No. 024-12163
Dear Mr. Park and Ms. Nicholson:
We are submitting
this letter on behalf of our client, Norhart Invest LLC (the “Company”), in response to the written comments of the
staff (the “Staff”) of the United States Securities and Exchange Commission (the “SEC”) contained
in your letter dated May 10, 2023 (the “Comment Letter”) in connection with the Company’s Amendment No. 2 to
Offering Statement on Form 1-A, as submitted with the SEC on April 26, 2023 (the “Offering Circular Amendment”).
For your convenience,
our responses are set forth below, with the headings and numbered items of this letter corresponding to the headings and numbered items
contained in the Comment Letter. Each of the comments from the Comment Letter is restated in bold and italics prior to the Company’s
response. Capitalized terms used but not defined in this letter shall have their respective meanings given to such terms in the Offering
Circular Amendment. All page number references in the Company’s responses are to page numbers in the Offering Circular Amendment,
which is being refiled concurrently with this response.
Amendment No. 2 to Form 1-A
filed April 26, 2023 General
1. Form 1-A requires that issuers specify the
price of the securities being offered. This means that the interest rate payable on the note must be calculable by investors or determined
by reference to a formula with publicly available inputs (for example, by reference to a benchmark). Your ability to change interest rates
for the Series A “Floating” Promissory Notes is within your complete discretion and therefore lacks transparency that is present
when a rate is calculable by investors or determined by reference to a formula with publicly available inputs. Please revise your pricing
method for the Series A “Floating” Promissory Notes to comply with Regulation A. For additional guidance,
please see Note 2 of Item 501(b)(3) from Regulation S-K.
Response:
We have made the changes as set forth in this Comment No. 1 to Amendment No. 3 of the Offering Circular on pages ___ and ____of Amendment
No. 3 of the Offering Circular.
2. We note that on page 2 and 23 you state that you “may offer Series
B “Fixed” Promissory Notes” and that on page 21 you “may offer [p]romissory [n]otes.” (emphasis added).
To comply with Rule 251(d)(3)(i)(F), the offering of the Series A notes and Series B notes must commence within two calendar days after
the qualification date and be offered continuously thereafter. Please revise your disclosure to confirm that you will offer the Series
A notes and Series B notes in compliance with Rule 251(d)(3)(i)(F).
Response:
We have added language on pages 2 and 23 of Amendment No. 3 of the Offering Circular to address this Comment No. 2.
3. Rule 253(b)(4) requires that you fix the volume of securities that you are
qualifying in this offering. Please state the number of Series A notes and the number of Series B notes you intend to qualify in this
offering.
Response:
We have added language on page __ of Amendment No. 3 to the Offering Circular to address Comment No. 3 to the Comment Letter.
4. Your response to comment 1 indicates that you intend to rely on Rule 253(b)
to change the interest rate on the notes. Please note that Rule 253(b) and (g)(1) are only available for the initial supplement filed
after qualification for the purposes of providing the pricing- related information omitted at qualification in reliance on Rule 253(b).
Response:
We have added language on page __ and page __ of the Offering Circular to address Comment No. 4 of the Comment Letter.
5. We note your response to comment 2. Please be advised that we are considering
further the rollover feature of the Series B “Fixed” Promissory Notes and may have additional comments.
Response:
Investor Series A "Floating"
Redemption Right, page 3
6. We reissue comment 4. Please describe in this section the specific risks
resulting in the company's inability to pay all of the Series A "Floating" Promissory Notes as they are redeemed.
Response:
We have added Language on page ___ of Amendment No. 3 of the Offering Circular to address this Comment No. 6.
Risk Factors
The Promissory Note Purchase Agreement
limits your rights in some important respects, page 7
7. In response to comment 5, we note your disclosure that investors "cannot
waive compliance with federal securities laws and the rules and regulations thereunder." Additionally, please disclose whether the
arbitration provision applies to purchasers in secondary transactions.
Response:
Use of Proceeds, page 14
8. It appears that you intend to use the proceeds
from this offering to acquire securities of your affiliate. For example, on page 14, you indicate that you may acquire preferred equity,
and, on page 20, you indicate that you “will use the proceeds of this offering primarily to purchase investments originated by Norhart
” Please note that to the extent you engage in the business of acquiring securities of another entity, you
are engaged in a distribution of the securities of that entity. See Securities Act Rule 140. To the extent you intend to acquire securities
of an affiliate, please identify such affiliate as co-issuer of the securities in this offering and Norhart Invest as underwriter of that
affiliate’s securities. In addition, please explain how you will comply with Securities Act Rule 251(b)(4).
Response:
We have added language on pages 14 and 20 of Amendment No. 3 to address this comment.
Please feel free to contact
the undersigned at (919) 264-4081 to discuss any of the above comments or responses.
Sincerely,
/s/ Donald T. Locke
Donald T. Locke
cc:
Tim Libertini
Brian Korn